Event Details:
Title: The Psychedelic Renaissance in Psychiatry
Presenter: Franklin King, MD
Director, Training and Education, Mass General Center for the Neuroscience of Psychedelics
Description: Dr. Franklin King will give an overview of the clinical and non-clinical use of psychedelics—past and present. He will discuss the mechanisms used and the current paradigm of psychedelic assisted therapies. Dr. King will conclude by sharing some of the challenges facing the use of psychedelics in a therapeutic context today.
Date/Time: Tuesday, April 5th | 8:00am – 9:00am US EDT
Cost: Free. CME credit available.
Download Flier here
Register for the Zoom event here.
Submit questions via the chat function on Zoom.
Trouble Shooting: If you have trouble with the live stream please email: [email protected]
For CME credit for virtual participation, please send an email between 8:00-8:30am on Tuesday, April 5th with your full name, degree and organization to [email protected].
Watch the Preview Interview with Dr. King below (1-minute)
Presenter Biography:
Dr. Franklin King is the director of training and education at the Mass General Center for the Neuroscience of Psychedelics and a clinical instructor at Harvard Medical School. His primary clinical and research interest is in the utilization of psychedelic-assisted psychotherapy to treat a variety of chronic psychiatric conditions, including depression and anxiety disorders, and in strategies to optimize these interventions for different patient populations. In addition, Dr. King teaches and supervises residents and fellows at Mass General, and practices clinically as a staff psychiatrist at the Center for Anxiety and Traumatic Stress Disorders as well as on the Acute Psychiatry Service in the Emergency Department.
Dr. King received his MD from the University of Massachusetts and completed a residency in psychiatry at Mass General and McLean Hospitals, serving as the chief resident on the Consultation-Liaison Service. Following graduation, he completed a fellowship in Consultation-Liaison Psychiatry as well as a research fellowship with the Mass General Cardiac Psychiatry Research Program